nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—ADRB1—Endothelin Pathways—ADCY10—nephrolithiasis	0.0398	0.0479	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0322	0.0388	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—AQP1—nephrolithiasis	0.021	0.0253	CbGpPWpGaD
Pseudoephedrine—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0174	0.102	CcSEcCtD
Pseudoephedrine—ADRB1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0165	0.0199	CbGpPWpGaD
Pseudoephedrine—ADRB2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0162	0.0195	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.0159	0.0191	CbGpPWpGaD
Pseudoephedrine—ADRB1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0139	0.0167	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0137	0.0165	CbGpPWpGaD
Pseudoephedrine—ADRB2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0136	0.0164	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0134	0.0161	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0128	0.0154	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0124	0.015	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0122	0.0147	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0113	0.0136	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0112	0.0135	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—SLC2A9—nephrolithiasis	0.0107	0.0129	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0104	0.0126	CbGpPWpGaD
Pseudoephedrine—ADRB1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0101	0.0122	CbGpPWpGaD
Pseudoephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0099	0.0119	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.0092	0.0111	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.009	0.0108	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00823	0.00992	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00823	0.00992	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—SLC7A9—nephrolithiasis	0.00819	0.00987	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—DGKH—nephrolithiasis	0.00819	0.00987	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00819	0.00987	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00815	0.00982	CbGpPWpGaD
Pseudoephedrine—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00814	0.0479	CcSEcCtD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00798	0.00961	CbGpPWpGaD
Pseudoephedrine—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00782	0.046	CcSEcCtD
Pseudoephedrine—TNF—Spinal Cord Injury—AQP1—nephrolithiasis	0.00781	0.00941	CbGpPWpGaD
Pseudoephedrine—MAOA—Biological oxidations—SLC26A1—nephrolithiasis	0.0077	0.00927	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00767	0.00924	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00729	0.00879	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00729	0.00879	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Other—CHRM3—nephrolithiasis	0.00717	0.00864	CbGpPWpGaD
Pseudoephedrine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00715	0.0421	CcSEcCtD
Pseudoephedrine—IL2—Signaling by GPCR—RGS14—nephrolithiasis	0.00696	0.00839	CbGpPWpGaD
Pseudoephedrine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00681	0.0401	CcSEcCtD
Pseudoephedrine—ADRA2A—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.0063	0.00759	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00624	0.00752	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00624	0.00752	CbGpPWpGaD
Pseudoephedrine—TNF—TGF-beta Receptor Signaling—SPP1—nephrolithiasis	0.00606	0.0073	CbGpPWpGaD
Pseudoephedrine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00598	0.0352	CcSEcCtD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0058	0.00699	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0058	0.00699	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ADCY10—nephrolithiasis	0.00572	0.00689	CbGpPWpGaD
Pseudoephedrine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00572	0.0336	CcSEcCtD
Pseudoephedrine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00566	0.0333	CcSEcCtD
Pseudoephedrine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0056	0.033	CcSEcCtD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00553	0.00666	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00553	0.00666	CbGpPWpGaD
Pseudoephedrine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00546	0.0321	CcSEcCtD
Pseudoephedrine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00535	0.0315	CcSEcCtD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00529	0.00637	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—SLC26A1—nephrolithiasis	0.00526	0.00634	CbGpPWpGaD
Pseudoephedrine—ADRB1—G alpha (s) signalling events—PTH—nephrolithiasis	0.00524	0.00631	CbGpPWpGaD
Pseudoephedrine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00523	0.0308	CcSEcCtD
Pseudoephedrine—IL2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00518	0.00624	CbGpPWpGaD
Pseudoephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00517	0.00623	CbGpPWpGaD
Pseudoephedrine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00515	0.0303	CcSEcCtD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00514	0.00619	CbGpPWpGaD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00514	0.00619	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00513	0.00618	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00513	0.00618	CbGpPWpGaD
Pseudoephedrine—ADRB2—G alpha (s) signalling events—PTH—nephrolithiasis	0.00512	0.00617	CbGpPWpGaD
Pseudoephedrine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00496	0.0292	CcSEcCtD
Pseudoephedrine—ADRA2A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00495	0.00597	CbGpPWpGaD
Pseudoephedrine—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00494	0.00595	CbGpPWpGaD
Pseudoephedrine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00494	0.0291	CcSEcCtD
Pseudoephedrine—NFATC1—Signaling Pathways—RGS14—nephrolithiasis	0.00486	0.00586	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ADCY10—nephrolithiasis	0.00484	0.00583	CbGpPWpGaD
Pseudoephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00484	0.00583	CbGpPWpGaD
Pseudoephedrine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00479	0.0282	CcSEcCtD
Pseudoephedrine—IL2—Signaling by GPCR—DGKH—nephrolithiasis	0.0047	0.00566	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ATP6V0A4—nephrolithiasis	0.00469	0.00565	CbGpPWpGaD
Pseudoephedrine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00464	0.0273	CcSEcCtD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00461	0.00556	CbGpPWpGaD
Pseudoephedrine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0046	0.027	CcSEcCtD
Pseudoephedrine—SLC6A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00458	0.00552	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00457	0.00551	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00455	0.00548	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00455	0.00548	CbGpPWpGaD
Pseudoephedrine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00453	0.0267	CcSEcCtD
Pseudoephedrine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0043	0.0253	CcSEcCtD
Pseudoephedrine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00424	0.0249	CcSEcCtD
Pseudoephedrine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00418	0.0246	CcSEcCtD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00418	0.00504	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00418	0.00504	CbGpPWpGaD
Pseudoephedrine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00413	0.0243	CcSEcCtD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00413	0.00497	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—RGS14—nephrolithiasis	0.00411	0.00495	CbGpPWpGaD
Pseudoephedrine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00406	0.0239	CcSEcCtD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00405	0.00488	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.004	0.00482	CbGpPWpGaD
Pseudoephedrine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00392	0.0231	CcSEcCtD
Pseudoephedrine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00376	0.0221	CcSEcCtD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00375	0.00452	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00374	0.00451	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00371	0.00447	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00371	0.00447	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—SPP1—nephrolithiasis	0.00364	0.00439	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—PTH—nephrolithiasis	0.00342	0.00412	CbGpPWpGaD
Pseudoephedrine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00341	0.0201	CcSEcCtD
Pseudoephedrine—IL2—Signaling by GPCR—CHRM3—nephrolithiasis	0.0034	0.0041	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00335	0.00404	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00334	0.00402	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00328	0.00396	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—DGKH—nephrolithiasis	0.00328	0.00396	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00319	0.00384	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00317	0.00382	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00317	0.00382	CbGpPWpGaD
Pseudoephedrine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00314	0.0185	CcSEcCtD
Pseudoephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00312	0.00375	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—PTH—nephrolithiasis	0.00311	0.00375	CbGpPWpGaD
Pseudoephedrine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00302	0.0178	CcSEcCtD
Pseudoephedrine—Rash—Hydrochlorothiazide—nephrolithiasis	0.003	0.0176	CcSEcCtD
Pseudoephedrine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00299	0.0176	CcSEcCtD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00298	0.00359	CbGpPWpGaD
Pseudoephedrine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00298	0.0175	CcSEcCtD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00295	0.00355	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00295	0.00355	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—SPP1—nephrolithiasis	0.00285	0.00343	CbGpPWpGaD
Pseudoephedrine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00282	0.0166	CcSEcCtD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00281	0.00338	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00281	0.00338	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—DGKH—nephrolithiasis	0.00278	0.00335	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00278	0.00335	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00273	0.00329	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00267	0.00322	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00263	0.00317	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00263	0.00317	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00261	0.00315	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00261	0.00315	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00258	0.00311	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00241	0.0029	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0024	0.00289	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CHRM3—nephrolithiasis	0.00237	0.00286	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—RGS14—nephrolithiasis	0.00235	0.00283	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00233	0.0028	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00233	0.0028	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00221	0.00266	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—RGS14—nephrolithiasis	0.00218	0.00263	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PTH—nephrolithiasis	0.00217	0.00262	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—RGS14—nephrolithiasis	0.00214	0.00257	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0021	0.00253	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00208	0.0025	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00205	0.00247	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CHRM3—nephrolithiasis	0.00203	0.00245	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CHRM3—nephrolithiasis	0.00201	0.00242	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00195	0.00234	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.00193	0.00233	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.00193	0.00233	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—PTH—nephrolithiasis	0.0019	0.00229	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00186	0.00224	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—PTH—nephrolithiasis	0.00186	0.00224	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PTH—nephrolithiasis	0.00184	0.00221	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00181	0.00218	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00177	0.00213	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GRHPR—nephrolithiasis	0.00174	0.00209	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00168	0.00203	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.00164	0.00198	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00162	0.00196	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—DGKH—nephrolithiasis	0.00159	0.00191	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00156	0.00188	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AGXT—nephrolithiasis	0.00155	0.00186	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00154	0.00185	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ADCY10—nephrolithiasis	0.00152	0.00183	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ADCY10—nephrolithiasis	0.00148	0.00179	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—DGKH—nephrolithiasis	0.00148	0.00178	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—DGKH—nephrolithiasis	0.00144	0.00174	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.00143	0.00172	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SLC26A1—nephrolithiasis	0.00132	0.00159	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APRT—nephrolithiasis	0.00132	0.00159	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00131	0.00158	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RGS14—nephrolithiasis	0.00129	0.00155	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RGS14—nephrolithiasis	0.00126	0.00152	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.00123	0.00148	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00122	0.00147	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00119	0.00144	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00117	0.00142	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.00116	0.0014	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00115	0.00138	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.00114	0.00137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.00111	0.00134	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SPP1—nephrolithiasis	0.00109	0.00131	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—PTH—nephrolithiasis	0.00107	0.00129	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00107	0.00129	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—PTH—nephrolithiasis	0.00105	0.00127	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.00104	0.00126	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CHRM3—nephrolithiasis	0.00104	0.00126	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.00103	0.00125	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PTH—nephrolithiasis	0.000976	0.00118	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.00097	0.00117	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PTH—nephrolithiasis	0.000954	0.00115	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000951	0.00115	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AQP1—nephrolithiasis	0.000938	0.00113	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SPP1—nephrolithiasis	0.000922	0.00111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000883	0.00106	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000879	0.00106	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000879	0.00106	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—DGKH—nephrolithiasis	0.000872	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000872	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000869	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000863	0.00104	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000853	0.00103	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—DGKH—nephrolithiasis	0.000853	0.00103	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CHRM3—nephrolithiasis	0.000848	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000808	0.000973	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000802	0.000966	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000789	0.000951	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000756	0.000911	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000734	0.000884	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000705	0.00085	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000705	0.00085	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000674	0.000812	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000655	0.000789	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000655	0.000789	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CHRM3—nephrolithiasis	0.00063	0.000759	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000627	0.000755	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CHRM3—nephrolithiasis	0.000616	0.000743	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTH—nephrolithiasis	0.000576	0.000694	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000573	0.00069	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000573	0.00069	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000567	0.000683	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTH—nephrolithiasis	0.000564	0.000679	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.00051	0.000614	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000474	0.000571	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000466	0.000562	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000433	0.000522	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000408	0.000492	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000369	0.000445	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SPP1—nephrolithiasis	0.000289	0.000349	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SPP1—nephrolithiasis	0.000283	0.000341	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000234	0.000282	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	0.000218	0.000262	CbGpPWpGaD
